GeneCode Ltd.

GeneCode, an drug development company, focused on the development of disease-modifying therapeutics to combat neurodegeneration, has developed a GDNF Mimetics platform that leverages the disease-modifying properties of GDNF to small molecules with drug-like properties. GeneCode has remarkably improved the properties of the identified hits, making them more active and effective, drug-like and better show their ability to combat neurodegeneration in Parkinson´s disease.